Radka Milanova - Allied Corp Chief Director

All Insiders USA . 
Stock . Allied Corp . Stakeholders . Insider . Radka Milanova
ALID Stock  USD 0.04  0.01  23.76%   

Insider

Radka Milanova is Chief Director of Allied Corp
Phone877 255 4337
Webhttps://allied.health

Allied Corp Management Efficiency

The company has return on total asset (ROA) of (0.6546) % which means that it has lost $0.6546 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (43.4399) %, meaning that it created substantial loss on money invested by shareholders. Allied Corp's management efficiency ratios could be used to measure how well Allied Corp manages its routine affairs as well as how well it operates its assets and liabilities.
Allied Corp currently holds 4.81 M in liabilities with Debt to Equity (D/E) ratio of 1.19, which is about average as compared to similar companies. Allied Corp has a current ratio of 0.05, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Allied Corp until it has trouble settling it off, either with new capital or with free cash flow. So, Allied Corp's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Allied Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Allied to invest in growth at high rates of return. When we think about Allied Corp's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

OriMoni MimonINC Research Holdings
36
Hermann LubbertBiofrontera
68
Mark BaldygaBiofrontera
N/A
Alex DasallaCollegium Pharmaceutical
N/A
Amos CohenINC Research Holdings
45
Richard MDCollegium Pharmaceutical
64
John WestoncbdMD Inc
N/A
Tejinder VirkAkanda Corp
42
BCom BAccAkanda Corp
44
Scott SudduthCollegium Pharmaceutical
N/A
Eugene IIIBiofrontera
39
Raymond CoffmancbdMD Inc
62
David EricksonEvolus Inc
N/A
Marlo ManningCollegium Pharmaceutical
N/A
Rami LevyINC Research Holdings
59
CCFP DipSportMedEvolus Inc
60
Thomas FlowAkanda Corp
46
Muthusamy RPhANI Pharmaceuticals
56
Elizabeth JDANI Pharmaceuticals
N/A
Jeff HolmBiofrontera
N/A
Advocate OhayonINC Research Holdings
35
Allied Corp., a medical cannabis production company, engages in the research, development, and production of cannabinoid health solutions in the United States. The company was incorporated in 2013 and is headquartered in Kelowna, Canada. ALLIED CORP is traded on OTC Exchange in the United States. Allied Corp [ALID] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Management Performance

Return On Equity-43.44
Return On Asset-0.65

Allied Corp Leadership Team

Elected by the shareholders, the Allied Corp's board of directors comprises two types of representatives: Allied Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Allied. The board's role is to monitor Allied Corp's management team and ensure that shareholders' interests are well served. Allied Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Allied Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
James McMillan, Chief Goods
Calum Hughes, Chairman Founder
Radka Milanova, Chief Director
Paul Bullock, COO Director
MBA MBA, VP Director
CPA BSc, Chief Officer

Allied Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Allied Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-43.44
Return On Asset-0.65
Operating Margin(26.04) %
Current Valuation27.14 M
Shares Outstanding97.04 M
Shares Owned By Insiders53.29 %
Price To Book52.50 X
Price To Sales130.80 X
Revenue165.6 K
Gross Profit74.12 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
GOOGAlphabet Inc Class C
GOOGAlphabet Inc Class C

Other Information on Investing in Allied OTC Stock

Allied Corp financial ratios help investors to determine whether Allied OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Allied with respect to the benefits of owning Allied Corp security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY